Inferior Vena Cava (IVC) Size in Acute Renal Failure
Status: | Completed |
---|---|
Conditions: | Renal Impairment / Chronic Kidney Disease |
Therapuetic Areas: | Nephrology / Urology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/10/2016 |
Start Date: | February 2014 |
End Date: | May 2016 |
Does the Inferior Vena Cava Size Assessment Help in the Management of Acute Kidney Injury in Critically Ill Patients?
Bedside ultrasonographic assessment of IVC size and IVC collapsibility index can be used to
guide the management of patients with acute kidney injury with and without volume overload
in the intensive care unit
guide the management of patients with acute kidney injury with and without volume overload
in the intensive care unit
Consecutive patients presenting to the intensive care unit with a diagnosis of acute renal
failure (defined as a 1.5 fold increase in plasma Creatinine level compared to baseline ).
Baseline characteristics will be recorded and followed for each patient, these include:
1. Demographics
2. Medical history
3. Hemodynamic parameter such as Central Venous Pressure (CVP), Mean Arterial Pressure
(MAP) , and measurement of superior vena cava (SVC) size by ultrasound.
4. Laboratory parameter such as chemistry, fractional excretion of sodium , fractional
excretion of urea , beta natriuretic peptide , albumin
5. Radiographic parameters
6. Echocardiographic parameters including Left Ventricular Ejection Fraction (LVEF), Right
Ventricular (RV) function and IVC size and variations
7. Mechanical ventilation
8. Daily fluid balance
Focused bedside ultrasound will be performed for each patient as part of their routine care
and initial assessment. The IVC size will be measured at the subcostal window, during
inspiration and expiration, using the (Sonosite) Cardiac probe P-21 (5-1 MHZ). The
measurement is obtained by applying the M-mode, perpendicular to the IVC axis and 2 cm
caudal from its junction with the right atrium.
In spontaneously breathing, non-ventilated patients, we will calculate the IVC
collapsibility index (IVC-CI) = [IVC max-IVC min]/IVC max.
Whereas in patients who are mechanically ventilated we will calculate their IVC variation
index (ΔIVC) = IVC max-IVC min/ IVC mean diameter.
IVC-CI, ΔIVC, IVC size will be used to classify patient as volume responders or
non-responder. Prior studies have suggested Intravascular volume depletion is likely present
when the, IVC<1 cm , IVC-CI is > 50% in spontaneously breathing patients and volume
responsiveness when the ΔIVC is ≥ 12% in mechanically ventilated patient .
The Fractional excretion of sodium as well as the fractional excretion of urea (when
diuretics are used) will be calculated to classify the etiology of the renal failure as
pre-renal or intrinsic renal failure.
Fluid balance as well as the change in plasma Creatinine level at 48 hours post admission
will be recorded.
Two groups of patients will be identified:
- Group 1 includes the patients who were managed in concordance with their IVC
measurements (Volume responders who had a positive fluid balance at 48 h post admission
and volume non responders who had an even or negative fluid balance at 48 hours post
admission).
- Group 2 includes the patients in whom the fluid management was discordant with the IVC
measurement.
Analyses will be done at 24 as well as 48 hours post admission.
failure (defined as a 1.5 fold increase in plasma Creatinine level compared to baseline ).
Baseline characteristics will be recorded and followed for each patient, these include:
1. Demographics
2. Medical history
3. Hemodynamic parameter such as Central Venous Pressure (CVP), Mean Arterial Pressure
(MAP) , and measurement of superior vena cava (SVC) size by ultrasound.
4. Laboratory parameter such as chemistry, fractional excretion of sodium , fractional
excretion of urea , beta natriuretic peptide , albumin
5. Radiographic parameters
6. Echocardiographic parameters including Left Ventricular Ejection Fraction (LVEF), Right
Ventricular (RV) function and IVC size and variations
7. Mechanical ventilation
8. Daily fluid balance
Focused bedside ultrasound will be performed for each patient as part of their routine care
and initial assessment. The IVC size will be measured at the subcostal window, during
inspiration and expiration, using the (Sonosite) Cardiac probe P-21 (5-1 MHZ). The
measurement is obtained by applying the M-mode, perpendicular to the IVC axis and 2 cm
caudal from its junction with the right atrium.
In spontaneously breathing, non-ventilated patients, we will calculate the IVC
collapsibility index (IVC-CI) = [IVC max-IVC min]/IVC max.
Whereas in patients who are mechanically ventilated we will calculate their IVC variation
index (ΔIVC) = IVC max-IVC min/ IVC mean diameter.
IVC-CI, ΔIVC, IVC size will be used to classify patient as volume responders or
non-responder. Prior studies have suggested Intravascular volume depletion is likely present
when the, IVC<1 cm , IVC-CI is > 50% in spontaneously breathing patients and volume
responsiveness when the ΔIVC is ≥ 12% in mechanically ventilated patient .
The Fractional excretion of sodium as well as the fractional excretion of urea (when
diuretics are used) will be calculated to classify the etiology of the renal failure as
pre-renal or intrinsic renal failure.
Fluid balance as well as the change in plasma Creatinine level at 48 hours post admission
will be recorded.
Two groups of patients will be identified:
- Group 1 includes the patients who were managed in concordance with their IVC
measurements (Volume responders who had a positive fluid balance at 48 h post admission
and volume non responders who had an even or negative fluid balance at 48 hours post
admission).
- Group 2 includes the patients in whom the fluid management was discordant with the IVC
measurement.
Analyses will be done at 24 as well as 48 hours post admission.
Inclusion Criteria:
- patients presenting to the intensive care unit with a diagnosis of acute renal
failure (defined as a 1.5 fold increase in plasma Creatinine level compared to
baseline)
Exclusion Criteria:
- Age<18 years
- Hemodialysis or continuous renal replacement therapy(CRRT)
- Untreated obstructive uropathy
- Pulmonary emboli
We found this trial at
1
site
940 NE 13th St
Oklahoma City, Oklahoma 73190
Oklahoma City, Oklahoma 73190
(405) 271-6458
University of Oklahoma Health Sciences Center The OU Health Sciences Center is composed of seven...
Click here to add this to my saved trials